Selected research
Industry Research
Liposome Service Industry Research Report 2026
Market perspective
The global Liposome Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Liposome Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Liposome Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Liposome Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Liposome Service include Acuitas Therapeutics, CD Bioparticles, Corden Pharma, Creative Biolabs, Creative Biostruct, Encapsula NanoSciences, Evonik, Exelead and FormuMax Scientific, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Liposome Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Liposome Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Liposome Service Market by Company
Acuitas Therapeutics
CD Bioparticles
Corden Pharma
Creative Biolabs
Creative Biostruct
Encapsula NanoSciences
Evonik
Exelead
FormuMax Scientific
FUJIFILM Pharmaceuticals USA
GMPriority Pharma
Lipoid
LIPOSOMA
Merck KGaA
Nippon Fine Chemical
PlantaCorp
Polymun
Liposome Service Segment by Type
Liposome Development Services
Liposome Customization Service
Liposome Encapsulation Services
Others
Liposome Service Segment by Application
Pharmaceutical
Life Sciences
Cosmetics and Skin Care Industrial
Others
Liposome Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Liposome Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liposome Development Services
- Liposome Customization Service
- Liposome Encapsulation Services
- Others
Applications
- Pharmaceutical
- Life Sciences
- Cosmetics and Skin Care Industrial
- Others
Companies covered
- Acuitas Therapeutics
- CD Bioparticles
- Corden Pharma
- Creative Biolabs
- Creative Biostruct
- Encapsula NanoSciences
- Evonik
- Exelead
- FormuMax Scientific
- FUJIFILM Pharmaceuticals USA
- GMPriority Pharma
- Lipoid
- LIPOSOMA
- Merck KGaA
- Nippon Fine Chemical
- PlantaCorp
- Polymun
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Liposome Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Liposome Development Services
- 2.2.3 Liposome Customization Service
- 2.2.4 Liposome Encapsulation Services
- 2.2.5 Others
- 2.3 Liposome Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical
- 2.3.3 Life Sciences
- 2.3.4 Cosmetics and Skin Care Industrial
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Liposome Service Breakdown Data by Type
- 3.1 Global Liposome Service Historic Market Size by Type (2021-2026)
- 3.2 Global Liposome Service Forecasted Market Size by Type (2027-2032)
4 Liposome Service Breakdown Data by Application
- 4.1 Global Liposome Service Historic Market Size by Application (2021-2026)
- 4.2 Global Liposome Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Liposome Service Market Perspective (2021-2032)
- 5.2 Global Liposome Service Growth Trends by Region
- 5.2.1 Global Liposome Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Liposome Service Historic Market Size by Region (2021-2026)
- 5.2.3 Liposome Service Forecasted Market Size by Region (2027-2032)
- 5.3 Liposome Service Market Dynamics
- 5.3.1 Liposome Service Industry Trends
- 5.3.2 Liposome Service Market Drivers
- 5.3.3 Liposome Service Market Challenges
- 5.3.4 Liposome Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Liposome Service Players by Revenue
- 6.1.1 Global Top Liposome Service Players by Revenue (2021-2026)
- 6.1.2 Global Liposome Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Liposome Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Liposome Service Head Office and Area Served
- 6.4 Global Liposome Service Players, Product Type & Application
- 6.5 Global Liposome Service Manufacturers Established Date
- 6.6 Global Liposome Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Liposome Service Market Size (2021-2032)
- 7.2 North America Liposome Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Liposome Service Market Size by Country (2021-2026)
- 7.4 North America Liposome Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Liposome Service Market Size (2021-2032)
- 8.2 Europe Liposome Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Liposome Service Market Size by Country (2021-2026)
- 8.4 Europe Liposome Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Liposome Service Market Size (2021-2032)
- 9.2 Asia-Pacific Liposome Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Liposome Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Liposome Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Liposome Service Market Size (2021-2032)
- 10.2 South America Liposome Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Liposome Service Market Size by Country (2021-2026)
- 10.4 South America Liposome Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Liposome Service Market Size (2021-2032)
- 11.2 Middle East & Africa Liposome Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Liposome Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Liposome Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Acuitas Therapeutics
- 12.1.1 Acuitas Therapeutics Company Information
- 12.1.2 Acuitas Therapeutics Business Overview
- 12.1.3 Acuitas Therapeutics Revenue in Liposome Service Business (2021-2026)
- 12.1.4 Acuitas Therapeutics Liposome Service Product Portfolio
- 12.1.5 Acuitas Therapeutics Recent Developments
- 12.2 CD Bioparticles
- 12.2.1 CD Bioparticles Company Information
- 12.2.2 CD Bioparticles Business Overview
- 12.2.3 CD Bioparticles Revenue in Liposome Service Business (2021-2026)
- 12.2.4 CD Bioparticles Liposome Service Product Portfolio
- 12.2.5 CD Bioparticles Recent Developments
- 12.3 Corden Pharma
- 12.3.1 Corden Pharma Company Information
- 12.3.2 Corden Pharma Business Overview
- 12.3.3 Corden Pharma Revenue in Liposome Service Business (2021-2026)
- 12.3.4 Corden Pharma Liposome Service Product Portfolio
- 12.3.5 Corden Pharma Recent Developments
- 12.4 Creative Biolabs
- 12.4.1 Creative Biolabs Company Information
- 12.4.2 Creative Biolabs Business Overview
- 12.4.3 Creative Biolabs Revenue in Liposome Service Business (2021-2026)
- 12.4.4 Creative Biolabs Liposome Service Product Portfolio
- 12.4.5 Creative Biolabs Recent Developments
- 12.5 Creative Biostruct
- 12.5.1 Creative Biostruct Company Information
- 12.5.2 Creative Biostruct Business Overview
- 12.5.3 Creative Biostruct Revenue in Liposome Service Business (2021-2026)
- 12.5.4 Creative Biostruct Liposome Service Product Portfolio
- 12.5.5 Creative Biostruct Recent Developments
- 12.6 Encapsula NanoSciences
- 12.6.1 Encapsula NanoSciences Company Information
- 12.6.2 Encapsula NanoSciences Business Overview
- 12.6.3 Encapsula NanoSciences Revenue in Liposome Service Business (2021-2026)
- 12.6.4 Encapsula NanoSciences Liposome Service Product Portfolio
- 12.6.5 Encapsula NanoSciences Recent Developments
- 12.7 Evonik
- 12.7.1 Evonik Company Information
- 12.7.2 Evonik Business Overview
- 12.7.3 Evonik Revenue in Liposome Service Business (2021-2026)
- 12.7.4 Evonik Liposome Service Product Portfolio
- 12.7.5 Evonik Recent Developments
- 12.8 Exelead
- 12.8.1 Exelead Company Information
- 12.8.2 Exelead Business Overview
- 12.8.3 Exelead Revenue in Liposome Service Business (2021-2026)
- 12.8.4 Exelead Liposome Service Product Portfolio
- 12.8.5 Exelead Recent Developments
- 12.9 FormuMax Scientific
- 12.9.1 FormuMax Scientific Company Information
- 12.9.2 FormuMax Scientific Business Overview
- 12.9.3 FormuMax Scientific Revenue in Liposome Service Business (2021-2026)
- 12.9.4 FormuMax Scientific Liposome Service Product Portfolio
- 12.9.5 FormuMax Scientific Recent Developments
- 12.10 FUJIFILM Pharmaceuticals USA
- 12.10.1 FUJIFILM Pharmaceuticals USA Company Information
- 12.10.2 FUJIFILM Pharmaceuticals USA Business Overview
- 12.10.3 FUJIFILM Pharmaceuticals USA Revenue in Liposome Service Business (2021-2026)
- 12.10.4 FUJIFILM Pharmaceuticals USA Liposome Service Product Portfolio
- 12.10.5 FUJIFILM Pharmaceuticals USA Recent Developments
- 12.11 GMPriority Pharma
- 12.11.1 GMPriority Pharma Company Information
- 12.11.2 GMPriority Pharma Business Overview
- 12.11.3 GMPriority Pharma Revenue in Liposome Service Business (2021-2026)
- 12.11.4 GMPriority Pharma Liposome Service Product Portfolio
- 12.11.5 GMPriority Pharma Recent Developments
- 12.12 Lipoid
- 12.12.1 Lipoid Company Information
- 12.12.2 Lipoid Business Overview
- 12.12.3 Lipoid Revenue in Liposome Service Business (2021-2026)
- 12.12.4 Lipoid Liposome Service Product Portfolio
- 12.12.5 Lipoid Recent Developments
- 12.13 LIPOSOMA
- 12.13.1 LIPOSOMA Company Information
- 12.13.2 LIPOSOMA Business Overview
- 12.13.3 LIPOSOMA Revenue in Liposome Service Business (2021-2026)
- 12.13.4 LIPOSOMA Liposome Service Product Portfolio
- 12.13.5 LIPOSOMA Recent Developments
- 12.14 Merck KGaA
- 12.14.1 Merck KGaA Company Information
- 12.14.2 Merck KGaA Business Overview
- 12.14.3 Merck KGaA Revenue in Liposome Service Business (2021-2026)
- 12.14.4 Merck KGaA Liposome Service Product Portfolio
- 12.14.5 Merck KGaA Recent Developments
- 12.15 Nippon Fine Chemical
- 12.15.1 Nippon Fine Chemical Company Information
- 12.15.2 Nippon Fine Chemical Business Overview
- 12.15.3 Nippon Fine Chemical Revenue in Liposome Service Business (2021-2026)
- 12.15.4 Nippon Fine Chemical Liposome Service Product Portfolio
- 12.15.5 Nippon Fine Chemical Recent Developments
- 12.16 PlantaCorp
- 12.16.1 PlantaCorp Company Information
- 12.16.2 PlantaCorp Business Overview
- 12.16.3 PlantaCorp Revenue in Liposome Service Business (2021-2026)
- 12.16.4 PlantaCorp Liposome Service Product Portfolio
- 12.16.5 PlantaCorp Recent Developments
- 12.17 Polymun
- 12.17.1 Polymun Company Information
- 12.17.2 Polymun Business Overview
- 12.17.3 Polymun Revenue in Liposome Service Business (2021-2026)
- 12.17.4 Polymun Liposome Service Product Portfolio
- 12.17.5 Polymun Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst